Shoulder Innovations, Inc. (SI) EV/Sales Ratio: 7.17x
Is Shoulder Innovations, Inc.’s EV/Sales ratio high or low?
Shoulder Innovations, Inc.'s EV/Sales ratio of 7.17x is 12% above its 1-year average of 6.41x, around the middle of its 1-year range (5.07x–9.48x).
As of Sunday, June 21, 2026.
SI EV/Sales Ratio Chart
SI EV/Sales Ratio Metrics
EV/SALES RATIO
7.17x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SI Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $384.69M | 7.17x | N/A | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.02x | 0.35x | 0.71x | 3.53x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | 1.14x | 1.26x | 1.71x | 2.17x |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 5.12x | 8.59x | 11.18x | 16.32x |
| Oscar Health, Inc. (OSCR)vs › | $7.36B | 0.38x | 0.23x | 0.31x | 0.45x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 3.28x | 3.42x | 3.67x | 4.56x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 3.80x | 4.63x | 4.20x | 4.24x |
| Tempus AI, Inc. (TEM)vs › | $8.87B | 7.25x | 11.33x | 12.15x | 12.15x |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 2.96x | 2.80x | 3.02x | 3.78x |
| Baxter International Inc. (BAX)vs › | $10.27B | 1.58x | 1.71x | 2.16x | 2.63x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Shoulder Innovations, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shoulder Innovations, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Shoulder Innovations, Inc. (SI)?
- The EV/Sales ratio for SI stock is 7.17x.
- Is Shoulder Innovations, Inc.'s EV/Sales ratio high or low?
- Shoulder Innovations, Inc.'s EV/Sales ratio of 7.17x is 12% above its 1-year average of 6.41x, around the middle of its 1-year range (5.07x–9.48x).
Shoulder Innovations, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-18 | 7.17x |
| 2026-06-17 | 6.95x |
| 2026-06-16 | 7.22x |
| 2026-06-15 | 7.01x |
| 2026-06-12 | 7.23x |
| 2026-06-11 | 7.25x |
| 2026-06-10 | 6.92x |
| 2026-06-09 | 5.94x |
| 2026-06-08 | 5.49x |
| 2026-06-05 | 5.54x |
| 2026-06-04 | 5.61x |
| 2026-06-03 | 5.37x |
| 2026-06-02 | 5.43x |
| 2026-06-01 | 5.50x |
| 2026-05-29 | 5.70x |
| 2026-05-28 | 5.86x |
| 2026-05-27 | 5.80x |
| 2026-05-26 | 5.84x |
| 2026-05-22 | 5.66x |
| 2026-05-21 | 5.85x |
| 2026-05-20 | 5.77x |
| 2026-05-19 | 5.79x |
| 2026-05-18 | 5.73x |
| 2026-05-15 | 6.06x |
| 2026-05-14 | 6.04x |
| 2026-05-13 | 5.25x |
| 2026-05-12 | 5.57x |
| 2026-05-11 | 5.51x |
| 2026-05-08 | 5.50x |
| 2026-05-07 | 5.31x |
| 2026-05-06 | 5.36x |
| 2026-05-05 | 5.38x |
| 2026-05-04 | 5.42x |
| 2026-05-01 | 5.63x |
| 2026-04-30 | 5.32x |
| 2026-04-29 | 5.10x |
| 2026-04-28 | 5.32x |
| 2026-04-27 | 5.64x |
| 2026-04-24 | 5.40x |
| 2026-04-23 | 5.44x |
| 2026-04-22 | 5.71x |
| 2026-04-21 | 5.79x |
| 2026-04-20 | 6.24x |
| 2026-04-17 | 6.28x |
| 2026-04-16 | 5.90x |
| 2026-04-15 | 6.36x |
| 2026-04-14 | 6.29x |
| 2026-04-13 | 6.20x |
| 2026-04-10 | 6.26x |
| 2026-04-09 | 6.20x |
| 2026-04-08 | 6.11x |
| 2026-04-07 | 6.06x |
| 2026-04-06 | 6.06x |
| 2026-04-02 | 6.11x |
| 2026-04-01 | 6.14x |
| 2026-03-31 | 6.08x |
| 2026-03-30 | 5.93x |
| 2026-03-27 | 5.78x |
| 2026-03-26 | 6.02x |
| 2026-03-25 | 6.02x |
| 2026-03-24 | 6.11x |
| 2026-03-23 | 6.02x |
| 2026-03-20 | 5.98x |
| 2026-03-19 | 6.30x |
| 2026-03-18 | 6.38x |
| 2026-03-17 | 6.33x |
| 2026-03-16 | 6.40x |
| 2026-03-13 | 6.20x |
| 2026-03-12 | 6.12x |
| 2026-03-11 | 5.85x |
| 2026-03-10 | 5.43x |
| 2026-03-09 | 5.63x |
| 2026-03-06 | 5.44x |
| 2026-03-05 | 5.45x |
| 2026-03-04 | 5.49x |
| 2026-03-03 | 5.46x |
| 2026-03-02 | 5.70x |
| 2026-02-27 | 5.71x |
| 2026-02-26 | 5.66x |
| 2026-02-25 | 5.66x |
| 2026-02-24 | 5.55x |
| 2026-02-23 | 5.67x |
| 2026-02-20 | 5.57x |
| 2026-02-19 | 5.60x |
| 2026-02-18 | 5.46x |
| 2026-02-17 | 5.46x |
| 2026-02-13 | 5.46x |
| 2026-02-12 | 5.79x |
| 2026-02-11 | 5.07x |
| 2026-02-10 | 5.53x |
| 2026-02-09 | 5.45x |
| 2026-02-06 | 5.31x |
| 2026-02-05 | 5.22x |
| 2026-02-04 | 5.42x |
| 2026-02-03 | 5.63x |
| 2026-02-02 | 6.05x |
| 2026-01-30 | 6.01x |
| 2026-01-29 | 6.06x |
| 2026-01-28 | 6.06x |
| 2026-01-27 | 6.06x |
| 2026-01-26 | 6.06x |
| 2026-01-23 | 6.37x |
| 2026-01-22 | 6.45x |
| 2026-01-21 | 6.12x |
| 2026-01-20 | 5.96x |
| 2026-01-16 | 5.91x |
| 2026-01-15 | 5.88x |
| 2026-01-14 | 5.71x |
| 2026-01-13 | 5.73x |
| 2026-01-12 | 6.01x |
| 2026-01-09 | 6.12x |
| 2026-01-08 | 6.45x |
| 2026-01-07 | 6.19x |
| 2026-01-06 | 6.23x |
| 2026-01-05 | 6.11x |
| 2026-01-02 | 6.11x |
| 2025-12-31 | 6.07x |
| 2025-12-30 | 6.49x |
| 2025-12-29 | 6.56x |
| 2025-12-26 | 6.54x |
| 2025-12-24 | 6.56x |
| 2025-12-23 | 6.49x |
| 2025-12-22 | 6.66x |
| 2025-12-19 | 6.58x |
| 2025-12-18 | 6.42x |
| 2025-12-17 | 6.54x |
| 2025-12-16 | 7.11x |
| 2025-12-15 | 6.15x |
| 2025-12-12 | 6.11x |
| 2025-12-11 | 6.39x |
| 2025-12-10 | 6.33x |
| 2025-12-09 | 6.38x |
| 2025-12-08 | 6.31x |
| 2025-12-05 | 6.52x |
| 2025-12-04 | 6.48x |
| 2025-12-03 | 6.53x |
| 2025-12-02 | 6.53x |
| 2025-12-01 | 6.16x |
| 2025-11-28 | 6.64x |
| 2025-11-26 | 6.95x |
| 2025-11-25 | 6.44x |
| 2025-11-24 | 6.40x |
| 2025-11-21 | 6.27x |
| 2025-11-20 | 5.85x |
| 2025-11-19 | 6.00x |
| 2025-11-18 | 6.35x |
| 2025-11-17 | 6.16x |
| 2025-11-14 | 6.27x |
| 2025-11-13 | 6.27x |
| 2025-11-12 | 6.42x |
| 2025-11-11 | 5.87x |
| 2025-11-10 | 5.68x |
| 2025-11-07 | 5.70x |
| 2025-11-06 | 5.79x |
| 2025-11-05 | 5.83x |
| 2025-11-04 | 5.77x |
| 2025-11-03 | 5.83x |
| 2025-10-31 | 6.07x |
| 2025-10-30 | 6.16x |
| 2025-10-29 | 6.07x |
| 2025-10-28 | 6.27x |
| 2025-10-27 | 6.39x |
| 2025-10-24 | 6.38x |
| 2025-10-23 | 6.52x |
| 2025-10-22 | 6.68x |
| 2025-10-21 | 6.42x |
| 2025-10-20 | 6.51x |
| 2025-10-17 | 6.49x |
| 2025-10-16 | 6.38x |
| 2025-10-15 | 6.28x |
| 2025-10-14 | 6.48x |
| 2025-10-13 | 6.31x |
| 2025-10-10 | 6.43x |
| 2025-10-09 | 6.85x |
| 2025-10-08 | 6.77x |
| 2025-10-07 | 6.82x |
| 2025-10-06 | 6.81x |
| 2025-10-03 | 6.32x |
| 2025-10-02 | 6.22x |
| 2025-10-01 | 6.23x |
| 2025-09-30 | 6.52x |
| 2025-09-29 | 6.52x |
| 2025-09-26 | 6.27x |
| 2025-09-25 | 6.49x |
| 2025-09-24 | 6.70x |
| 2025-09-23 | 6.97x |
| 2025-09-22 | 7.35x |
| 2025-09-19 | 7.54x |
| 2025-09-18 | 7.66x |
| 2025-09-17 | 7.77x |
| 2025-09-16 | 8.24x |
| 2025-09-15 | 7.82x |
| 2025-09-12 | 8.24x |
| 2025-09-11 | 7.86x |
| 2025-09-10 | 6.62x |
| 2025-09-09 | 7.84x |
| 2025-09-08 | 9.41x |
| 2025-09-05 | 8.80x |
| 2025-09-04 | 9.04x |
| 2025-09-03 | 8.91x |
| 2025-09-02 | 9.48x |
| 2025-08-29 | 8.78x |
| 2025-08-28 | 8.78x |
| 2025-08-27 | 9.33x |
| 2025-08-26 | 8.85x |
| 2025-08-25 | 8.90x |
| 2025-08-22 | 7.57x |
| 2025-08-21 | 7.27x |
| 2025-08-20 | 7.22x |
| 2025-08-19 | 7.41x |
| 2025-08-18 | 8.50x |
| 2025-08-15 | 8.36x |
| 2025-08-14 | 8.17x |
| 2025-08-13 | 7.82x |
| 2025-08-12 | 7.82x |
| 2025-08-11 | 7.25x |
| 2025-08-08 | 7.39x |
| 2025-08-07 | 7.25x |
| 2025-08-06 | 7.77x |
| 2025-08-05 | 8.40x |
| 2025-08-04 | 8.47x |
| 2025-08-01 | 8.46x |
| 2025-07-31 | 8.92x |
Related Metrics
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Alan J. Lane